✦ LIBER ✦

The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer

✍ Scribed by Meng-Fen Wu; S. G. Hilsenbeck; Yee L. Tham; Rita Kramer; R. M. Elledge; J. C. Chang; L. C. Friedman

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 204 KB
Volume: 118
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0425-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The addition of hormone therapy to tamox

The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer

✍ Cynthia R. Osborne; Anita Duncan; Scot Sedlacek; Devchand Paul; Frankie Holmes; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 170 KB

Dermatoglyphics in the identification of

Dermatoglyphics in the identification of women either with or at risk for breast cancer

✍ Seltzer, Murray H. ;Plato, Chris C. ;Fox, Kathleen M. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Fingerprints and palm prints were studied in 78 breast cancer patients, 391 patients at increased risk for developing breast cancer, and 64 control patients for the purpose of finding a pattern that would identify those women with breast cancer or those who are predisposed to its development. A pat

The impact of having relatives affected

The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer

✍ Silvia van Dooren; Caroline Seynaeve; Adriana J Rijnsburger; Hugo J Duivenvoorde 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 97 KB

Factors implicated in the decision wheth

Factors implicated in the decision whether or not to join the tamoxifen trial in women at high familial risk of breast cancer

✍ E. Lovegrove; N. Rumsey; D. Harcourt; S.J. Cawthorn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 3 views

Why, given similar medical circumstances-high familial risk of breast cancer -will some women elect to join a trial of drugs designed to reduce that risk but others choose not to take part? The aim of this study was to identify measurable differences between women who elect to join a placebo-control

Exploratory study of the feasibility and

Exploratory study of the feasibility and utility of the colored eco-genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer

✍ Peters, June A. ;Kenen, Regina ;Giusti, Ruthann ;Loud, Jennifer ;Weissman, Nancy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract We report here the results of an exploratory feasibility study of the colored eco‐genetic relationship map (CEGRM), a novel, recently‐developed psychosocial assessment tool, which incorporates features of the genetic pedigree, family systems genogram, and ecomap. The CEGRM presents a si

Comparison of cytomorphology in specimen

Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer

✍ Carola M. Zalles; Bruce F. Kimler; Marie Simonsen; Julie L. Clark; Trina Metheny 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 242 KB